Skip to content

Boston Scientific BSX Gain (Loss) on Investments

Gain (Loss) on Investments at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$67.32B-37.5%
P/E18.9×-34.3×
P/S3.3×-2.9×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's gain (loss) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's gain (loss) on investments?
Boston Scientific (BSX) reported gain (loss) on investments of $158M in Q1 2026.
How has Boston Scientific's gain (loss) on investments changed year-over-year?
Boston Scientific's gain (loss) on investments increased by 664.3% year-over-year, from -$28M to $158M.
What is the long-term trend for Boston Scientific's gain (loss) on investments?
Over 2 years (2021 to 2024), Boston Scientific's gain (loss) on investments has grown at a -45.4% compound annual growth rate (CAGR), from $265M to -$79M.
What does gain (loss) on investments mean?
The profit or loss generated from selling or revaluing investment assets.
How do you interpret gain (loss) on investments?
Positive gains boost net income but are non-operating; losses may indicate poor performance of venture or strategic investment portfolios.
How does gain (loss) on investments compare across companies?
Varies significantly based on the size of the company's corporate venture capital arm.